SGX Regco grants SAM Holdings’ extension for FY 2024 results

The company filed the application on 16 August with SGX Regco.

The Singapore Institute of Advanced Medicine Holdings Ltd. (SAM Holdings) application for extension to submit its fiscal year 2024 (FY 2024) earnings results has been granted by the Singapore Exchange Regulation (SGX Regco), according to a bourse filing.

This grants the company a two-month extension to release its FY 2024 results by 29 October and to convene its annual general meeting (AGM) by 31 December.

They were also granted a two-month extension for the issuance of their AR2024 by 16 December, being at least 14 days before the date of its AGM.

Additionally, the company is also expected to file an application to the Accounting and Corporate Regulatory Authority (ACRA) for an extension to hold its AGM 2024.

Follow the link for more news on

Singapore

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia